Cardamom Health Executives 2026-Big Changes Ahead
- 01. Cardamom Health Executives 2026: Who's Leading the Firm?
- 02. Core Executive Leadership Team
- 03. Executive Experience and Background Snapshot
- 04. Executive Tenures and Stability Signal
- 05. Table of Key Cardamom Health Executives (2026)
- 06. Board and Governance Implications
- 07. Leadership Alignment with AI and Managed Services Strategy
Cardamom Health Executives 2026: Who's Leading the Firm?
As of 2026, the Cardamom Health executive team is anchored by Chief Executive Officer Vivek Swaminathan, who continues to steer the company's growth across health IT, data analytics, and AI-enabled managed services. Alongside him, a compact but senior leadership group includes Sriram Devarakonda as Chief Technology Officer, Adam Dial as Chief Customer Officer, and Andy Mueller as Chief Operating Officer, with additional executives in finance, people, and business development rounding out the core leadership layer.
This structure positions Cardamom Health as a nimble, minority-owned health IT services firm that can scale delivery while maintaining tight alignment between technology, client outcomes, and operational execution.
Core Executive Leadership Team
The public-facing leadership roster at Cardamom Health in 2026 reflects a blend of clinical, technical, and business backgrounds tailored to the complexity of modern health systems. The following individuals are consistently presented as central executives in company materials and third-party profiles as of early 2026:
- Vivek Swaminathan - Chief Executive Officer
- Sriram Devarakonda - Chief Technology Officer (also identified as a founder)
- Adam Dial - Chief Customer Officer
- Andy Mueller - Chief Operating Officer
- Jim Deischer - Vice President of Finance
- Emily Nidetz - Vice President of People
- Bridget Bell - Vice President of Business Development
Each of these roles maps to a distinct pillar of Cardamom Health's operating model: Vivek oversees strategy and capital markets, Sriram leads data, AI, and EHR engineering, Adam drives client satisfaction and contract performance, and Andy manages delivery operations, including project management and staffing.
Executive Experience and Background Snapshot
Holding Vivek Swaminathan at the top of the Cardamom Health org chart signals a deliberate focus on founder-driven continuity amid rapid growth. He has been publicly profiled in Wisconsin-based media as a Madison-area entrepreneur with deep roots in health IT consulting and EHR implementations, giving him direct credibility with both health systems and private-equity partners.
Sriram Devarakonda, as Chief Technology Officer, brings over two decades of experience in healthcare data and analytics, which he has described in 2026 thought-leadership pieces as critical to turning AI from pilot projects into measurable workflow improvements. His dual role as founder and CTO underscores that Cardamom Health's technology roadmap is directly tied to its executive agenda, not outsourced to a separate R&D function.
A typical internal hierarchy in 2026 would look like this:
- Chief Executive Officer - Vivek Swaminathan (overall strategy, P&L, investor relations)
- Chief Technology Officer - Sriram Devarakonda (data, analytics, AI, EHR architecture)
- Chief Operating Officer - Andy Mueller (delivery, staffing, project-portfolio management)
- Chief Customer Officer - Adam Dial (client success, account management, service level agreements)
- VP Finance - Jim Deischer (budgeting, financial reporting, M&A or capital-raise support)
- VP People - Emily Nidetz (talent acquisition, HR, culture, DEI initiatives)
- VP Business Development - Bridget Bell (sales, partnerships, conference outreach such as HFMA 2026)
Executive Tenures and Stability Signal
Tenure data from public profiles and investor-platform snapshots indicate that the core Cardamom Health leadership team has remained largely stable since at least 2024, with Vivek, Sriram, and Andy appearing in founder and executive roles across multiple years. This continuity is notable in an industry where health IT consultancies often rotate leadership after major funding rounds or acquisitions.
The 2026 minority investment by Valspring Capital, announced in January 2026, added Yumin Choi, co-founder and managing partner of Valspring, to Cardamom Health's board of directors, but did not displace the existing executive team. That move signals investor confidence in the current leadership's ability to scale AI-driven managed services and EHR advisory work without a wholesale management overhaul.
Table of Key Cardamom Health Executives (2026)
The table below summarizes the individuals most closely associated with Cardamom Health's executive leadership in 2026, based on current public profiles and org-chart references.
| Executive Name | Role | Primary Focus Area (2026) | Notable Background Signal |
|---|---|---|---|
| Vivek Swaminathan | Chief Executive Officer | Company strategy, P&L, investor relations | Founder-CEO with roots in health IT consulting and EHR implementations |
| Sriram Devarakonda | Chief Technology Officer | Data, analytics, AI, EHR architecture | Over 20 years in healthcare data and technology; also listed as founder |
| Adam Dial | Chief Customer Officer | Client success, account management, service levels | Customer-experience-focused executive within health IT services |
| Andy Mueller | Chief Operating Officer | Project delivery, staffing, day-to-day operations | Operational leader for scaling managed services and EHR work |
| Jim Deischer | VP Finance | Financial planning, reporting, funding follow-through | Finance executive supporting growth and capital-raise activities |
| Emily Nidetz | VP People | Talent, culture, HR strategy | HR leader focused on building diverse, high-performance teams |
| Bridget Bell | VP Business Development | Sales, partnerships, conference outreach | Business-development executive active in HFMA and regional health-finance forums |
This table reflects a leadership lineup deliberately balanced between technical depth, customer-relationship savvy, and financial discipline, which is consistent with Cardamom Health's positioning as a managed-services partner rather than a pure product vendor.
Board and Governance Implications
Alongside the operating executives, the 2026 governance structure of Cardamom Health now includes external representation from Valspring Capital through Yumin Choi's board appointment. Board-level oversight in 2026 therefore combines founder-CEO continuity with private-equity governance practices, particularly around AI-driven managed services and EHR modernization contracts.
Industry analysts in 2026 have noted that minority-owned health IT firms like Cardamom Health are increasingly attractive to growth-oriented investors seeking exposure to AI-enabled analytics without acquiring full-stack EHR vendors. This macro trend likely influenced both the Valspring investment and the decision to keep the core executive team intact while scaling engineering and client-delivery capacity.
Leadership Alignment with AI and Managed Services Strategy
In 2026, the Cardamom Health executive team is publicly framing its strategy around three interconnected themes: managed EHR services, AI-driven analytics, and outsourced digital-health operations for health systems. Sriram Devarakonda's thought-leadership articles for 2026 explicitly connect AI-governance, ambient documentation, and agentic workflows to the firm's delivery model, suggesting that the CTO's technical roadmap is tightly synchronized with the CEO's commercial agenda.
Bridget Bell, in her role as VP of Business Development, has been active in regional health-finance conferences such as HFMA 2026 spring events, which signals that Cardamom Health's executives are targeting conversations with CFOs and revenue-cycle leaders as much as with CIOs and CMIOs. This dual-persona outreach-financial and clinical-reinforces the executive narrative that managed services and AI-enabled analytics should be evaluated on ROI and operational efficiency, not just on technical novelty.
Team-building posts on the company's social channels in 2026 highlight collaborative, project-based work and rapid onboarding of new technical talent, which aligns with the lean executive structure and suggests that the leadership team is actively promoting a "no-egos, outcomes-first" culture. That messaging is consistent with a services-oriented firm that must scale quickly without inflating overhead.
Stability in the CEO-CTO-COO triad, combined with the addition of a private-equity board member, suggests that Cardamom Health's leadership intends to pursue an organic-growth path rather than a quick exit via acquisition. If 2026 revenue and client-count metrics materialize in line with the publicized AI-strategy story, the current executive cohort will likely be viewed as a key differentiator in the crowded health IT consulting landscape.
Everything you need to know about Cardamom Health Executives 2026 Big Changes Ahead
How is the executive team structured?
Across public profiles and org-chart tools, Cardamom Health maintains a relatively flat executive structure, with no large "C-suite" bureaucracy separating the CEO from delivery and client leaders. This design is consistent with a boutique-style health IT services firm that prioritizes fast decision-making and high-touch client engagement over hierarchical corporate layers.
Who is the CEO of Cardamom Health in 2026?
Vivek Swaminathan remains the Chief Executive Officer of Cardamom Health as of 2026, continuing the founder-led leadership model the company has maintained since its early years. His profile in local and trade outlets emphasizes hands-on experience in health IT consulting, EHR implementation, and data strategy, which helps position Cardamom Health as a technically grounded services partner rather than a generic IT outsourcing shop.
Does Cardamom Health have a CTO in 2026?
Yes: Sriram Devarakonda serves as the Chief Technology Officer of Cardamom Health in 2026, a role that also ties back to his status as a founder. In that capacity he is responsible for data architecture, AI modeling, and the integration of analytics and ai-enabled tools into EHR platforms and managed-service offerings, which aligns with Cardamom Health's 2026 AI-focused thought-leadership and service expansion.
Is there a COO leading day-to-day operations?
Yes, Andy Mueller is listed as the Chief Operating Officer of Cardamom Health in current public profiles, with accountability for project delivery, staffing, and operational efficiency. This structure allows the CEO and CTO to focus on strategy and technology vision while Mueller manages the execution of service contracts and client-facing workflows, which is especially important for a growing health IT services firm juggling multiple EHR environments and AI-enabled analytics projects.
How does the executive team influence company culture?
Emily Nidetz, the VP of People, is positioned as the executive directly responsible for shaping Cardamom Health's culture, including diversity, inclusion, and professional development for a growing consulting workforce. In a 2025-2026 context where health IT firms face stiff competition for data engineers and AI specialists, this focus on people strategy helps differentiate Cardamom Health beyond check-the-box DEI statements.
What should partners or investors watch for in 2026?
For partners and investors tracking Cardamom Health in 2026, the most important signal is whether the current executive team successfully translates its AI-strategy narrative into measurable delivery growth and client retention. Third-party analytics platforms and investor databases already list the firm as having raised over $1 million in venture capital, which implies that the founders and senior executives are under pressure to demonstrate concrete expansion of managed-services contracts and EHR-related advisory work.